Current ranking of intrapleural fibrinolysis in the treatment of loculated exudative fibrinous pleural effusions, pleural empyemas and haemothorax;Stellenwert der intrapleuralen Fibrinolyse bei der Therapie exsudativer fibrinoser gekammerter Pleuraergusse, beim Pleuraempyem und Hamatothorax

Pneumologie

Volumn 53, Issue 8, 1999, Pages 373-384

  Kemper, Peter ^a   Kohler D ^a  

^a KRANKENHAUS KLOSTER GRAFSCHAFT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; SODIUM CHLORIDE; STREPTOKINASE; UROKINASE;

ANTIBODY RESPONSE; CATHETER; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; FIBRIN DEPOSITION; FIBRIN FORMATION; FIBRINOLYSIS; HEMATOTHORAX; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; LUNG SURGERY; META ANALYSIS; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THORAX DRAINAGE; TUBE;

EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HEMOTHORAX; HUMANS; PLEURA; PLEURAL EFFUSION; THROMBOLYTIC THERAPY;

EID: 0032772512     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Alfageme I, Munoz F, Pena N, Umbria S. Empyema of the thorax in adults. Etiology, microbiologic findings and management. Chest 1993; 103: 839-843
2. Alfageme I, Vazquez R. Ventricular fibrillation after intrapleural urokinase. Intensive Care Med 1997; 23: 352
3. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991; 99: 1162-1165
4. Aye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and hemothorax. Am J Surg 1991; 161: 560-562
5. Bergh NP, Ekroth R, Larsson S, Nagy P. Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg 1977; 11: 265-268
6. Berglin E, Ekroth R, Teger-Nilsson AC, William-Olsson G. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis. Thorac Cardiovasc Surg 1981; 29: 124-126
7. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990; 322: 890-897
8. Bignon J, Gee JBL. Pleural fibrogenesis. In: Chretien J, Bignon J, Hirsch A (editors). The pleura in health and disease. New York: Marcel Dekker; 1985, 417-443
9. Bouros D, Schiza S, Panagou P, Drositis J, Siafakas N. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema. Thorax 1994; 49: 852-855
10. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions. Am J Respir Crit Care Med 1997; 155: 291-295
11. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999; 159: 37-42
12. Bouros D, Schiza S, Tzanakis N, Drositis J, Siafakas N. Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J 1996; 9: 1656-1659
13. Bux M, Baig MK, Rodrigues E, Armstrong D, Brown A. Antibody response to topical streptokinase. Journal of Wound Care 1997; 6: 70-73
14. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111: 275-279
15. Chin NK, Lim TK. Treatment of complicated parapneumonic effusions and pleural empyema: a four-year prospective study. Singapore Med J 1996; 37: 631-635
16. Christensen LR. Streptococcal fibrinolysis: a proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysin. J Gen Physiol 1945; 28: 363-383
17. Christensen LR, MacLeod CM. A proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors. J Gen Physiol 1945; 28: 559-583
18. Cohen ML, Finch IJ. Transcatheter intrapleural urokinase for loculated pleural effusion. Chest 1994; 105: 1874-1876
19. Creech JO, DeBaky ME, Amspacher WH, Mahaffey DE. The intrathoracic use of streptokinase-streptodornase. Am Surg 1953; 19: 128-147
20. Davies CWH, Lok S, Davies RJO. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998; 157: 328-330
21. Davies RJO, Gleeson FV. The diagnosis and management of pleural empyema. Curr Opin Pulm Med 1998; 4: 185-190
22. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52: 416-421
23. Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM 1996; 89: 285-289
24. Fraedrich G, Hofmann D, Effenhauser P, Jander R. Instillation of fibrinolytic enzymes in the treatment of pleural empyema. Thorac Cardiovasc Surg 1982; 30: 36-38
25. French SW, Rumer GF. Limited thoracotomy and enzymatic therapy in the treatment of early clotted hemothorax. US Armed Forces Medical Journal IX 1958; 7: 949-956
26. Frye MD, Jarratt M, Sahn SA. Acute hypoxemic respiratory failure following intrapleural thrombolytic therapy for hemothorax. Chest 1994; 105: 1595-1596
27. Glauser FL, Otis PT, Levine RI, Smith WR. In vitro pleural fluid clottability and fibrinogen content. Chest 1975; 68: 205-208
28. Godley PJ, Bell RC. Major hemorrhage following administration of intrapleural streptokinase. Chest 1984; 86: 486-487
29. Goehring WO, Grant JJ. Allergic reaction to streptokinase-streptodornase solution given intrapleurally. JAMA 1953; 152: 1429-1430
30. Green C. Antistreptokinase titres after topical streptokinase. Lancer 1993; 341: 1602-1603
31. Guschall WR, Dittrich I, Poggemann V, Liebetrau G. Intrapleurale Fibrinolyse mit Urokinase zur Behandlung des chronischen Empyems. Atemw Longenkrkh 1998; 24: 12-17
32. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156
33. Handman HP, Reuman PD. The use of urokinase for loculated thoracic empyema in children: a case report and review of the literature. Pediatr Infect Dis J 1993; 12: 958-959
34. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. Am J Respir Crit Care Med 1995; 151: 1700-1708
35. Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Am Rev Respir Dis 1992; 145: 680-684
36. Iaye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and hemothorax. Am J Surg 1991; 161: 560-562
37. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991; 144: 187-194
38. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84: 695-705
39. Inci I, Özcelik C, Ülkü R, Tuna A, Eren N. Intrapleural fibrinolytic treatment of traumatic clotted hemothorax. Chest 1998; 114: 160-165
40. Jalihal S, Morris GK. Antistreptokinase titres after intravenous streptokinase. Lancet 1990; 335: 184-185
41. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, Delgado R, Cicero R, Ibarra-Perez C, Arroliga AC, Padua A, Portales A, Villarreal A, Perez-Romo A. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema. A multicenter trial. Chest 1996; 109: 1514-1519
42. Kaplan DK. Treatment of empyema thoracis. Thorax 1994; 49: 845-846
43. Kemper P. Parapneumonischer Pleuraerguß und Pleuraempyem. Atemw.-Lungenkrkh 1998; 24: 416-424
44. Kornecki A, Sivan Y. Treatment of loculated pleural effusion with intrapleural urokinase in children. J Pediatr Surg 1997; 32: 1473-1475
45. Kraan JK. The treatment of postoperative haemothorax following pulmonary resection with a streptokinase-streptodornase preparation. Arch Chir Neerland VI 1954; 1: 29-40
46. Krishnan S, Amin N, Dozor AJ, Stringel G. Urokinase in the management of complicated parapneumonic effusions in children. Chest 1997; 112: 1579-1583
47. Kroegel C, Matthys H, Hamm H. Parapneumonischer Pleuraerguß und thorakales Empyem. In: KH Rühle (Hrsg.). Pleuraerkrankungen. Stuttgart, Berlin, Köln: W. Kohlhammer; 1997, 100-112
48. Laisaar T, Puttsepp E, Laisaar V. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas. Thorac Cardiovasc Surg 1996; 44: 252-256
49. Lee HS. How safe is the readministration of streptokinase? Drug Saf 1995; 13: 76-80
50. Lee HS, Yule S, McKenzie A, Cross S, Reid T, Davidson R, Jennings K. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres. Eur Heart J 1993; 14: 1640-1643
51. Lee KS, Im JG, Kim YH, Hwang SH, Bae WK, Lee BH. Treatment of thoracic multiloculated empyemas with intracavitary urokinase: a prospective study. Radiology 1991; 179: 771-775
52. LeMense GP, Strange Ch, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest 1995; 107: 1532-1537
53. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997; 10: 476-481
54. Light RW. Pleural diseases. Dis Mon 1992; 38: 261-331
55. Limthongkul S, Charoenlap P, Wongthim S, Udompanich V, Nuchprayoon C. Pneumonia with pleural effusions. J Med Assoc Thai 1994; 77: 225-230
56. Loddenkemper R. Pleuraerguß. In: Konietzko N, Wendel H, Wiesner B (Hrsg.). Erkrankungen der Lunge. Berlin, New York: Walter de Gruyter; 1995. Kap. XXXII-1
57. Lynch M, Pentecost BL, Littler WA, Stockley RA. The distribution of antibodies to streptokinase. Postgrad Med J 1996; 72: 290-292
58. Lysy Y, Gavish A, Lieberson A, Werczberger A, Reifen R, Dudai M. Intrapleural instillation of streptokinase in the treatment of organizing empyema. Isr J Med Sci 1989; 25: 284-287
59. Matsumoto AH. Image-guided drainage of complicated pleural effusions and adjunctive use of intrapleural urokinase. Chest 1995; 108: 1190-1191
60. Milstone H. A factor in normal human blood which participates in streptococcal fibrinolysis. J Immunol 1941; 42: 109-116
61. Mitchell ME, Alberts WM, Chandler KW, Goldman AL. Intrapleural streptokinase in management of parapneumonic effusions. Report of series and review of literature. J Fla Med Assoc 1989; 76: 1019-1022
62. Moulton JS, Benkert RE, Weisiger KH, Chambers JR. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest 1995; 108: 1252-1259
63. Moulton JS, Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase. AJR 1989; 153: 941-945
64. Muers MF. Streptokinase for empyema. Lancet 1997; 349: 1491-1492
65. Park CS, Chung WM, Lim MK, Suh CH, Chung WK. Transcatheter instillation of urokinase into loculated pleural effusion: analysis of treatment effect. Am J Roentgenol 1996; 167: 649-652
66. Perri JA, Stahfeld KR, Villella ER, Simone ST, Lally ME. The management of anaphylactoid reactions to urokinase. J Vasc Surg 1994; 20: 846-847
67. Philip-Joet F, Alessi MC, Philip-Joet C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995; 8: 1352-1356
68. Pollak JS, Passik CS. Intrapleural urokinase in the treatment of loculated pleural effusions. Chest 1994; 105: 868-873
69. Robinson LA, Moulton AL, Fleming WH, Alonso A, Galbraith TA. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Ann Thorac Surg 1994; 57: 803-813
70. Rodriguez-Panadero F, Segado A, Martin Juan J, Ayerbe R, Torres Garcia I, Castillo J. Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 1995; 151: 785-790
71. Rosen H, Nadkarni V, Theroux M, Padman R, Klein J. Intrapleural streptokinase as adjunctive treatment for persistent empyema in pediatric patients. Chest 1993; 103: 1190-1193
72. Roupie E, Bouabdallah K, Delclaux C, Brun-Buisson C, Lemaire F, Vasile N, Brochard L. Intrapleural administration of streptokinase in complicated purulent pleural effusion: a CT-guided strategy. Intensive Care Med 1996; 22: 1351-1353
73. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993; 148: 813-817
74. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998; 53, Suppl 2: 565-572
75. Sherry S, Tillett WS, Read CTH. The use of Streptokinase-Streptodornase in the treatment of hemothorax. J Thorac Surg 1950; 20: 393-417
76. Soler M, Wyser C, Bollinger CT, Perruchoud AP. Treatment of early parapneumonic empyema by "medical" thoracoscopy. Schweiz Med Wochenschr 1997; 127: 1748-1753
77. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis 1993; 147: 962-966
78. Strange C, Baumann MH, Sahn SA, Idell S. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 1995; 151: 508-515
79. Strange C, Sahn SA. Management of parapneumonic pleural effusions and empyema. Infect Dis Clin North Am 1991; 5: 539-559
80. Strange C, Sahn SA. The clinician's perspective on parapneumonic effusions and empyema. Chest 1993; 103: 259-261
81. Stringel G, Hartman AR. Intrapleural instillation of urokinase in the treatment of loculated pleural effusions in children. J Pediatr Surg 1994; 29: 1539-1540
82. Taylor RFH, Rubens MB, Pearson MC, Barnes NC. Intrapleural streptokinase in the management of empyema. Thorax 1994; 49: 856-859
83. Temes RT, Follis F, Kessler RM, Pett SB, Wernly JA. Intrapleural fibrinolytics in management of empyema thoracis. Chest 1996; 110: 102-106
84. Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58: 485-502
85. Tillett WS, Johnson AJ, McCarty WR. The intravenous infusion of the streptococcal fibrinolytic principle (Streptokinase) into patients. J Clin Invest 1955; 34: 169-185
86. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest 1949; 28: 173-190
87. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of chronic empyema. J Thorac Surg 1951; 21: 325-341
88. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg 1951; 21: 275-297
89. Vidovich RR, Heiselman DE, Hudock D. Treatment of urokinase-related anaphylactoid reaction with intravenous famotidine. Ann Pharmacother 1992; 26: 782-783
90. Viscardi RM, Broderick K, Sun CJ, Yale-Loehr AJ, Hessamfar A, Taciak V, Burke KC, Koenig KB, Idell S. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 492-499
91. Vogelzang RL, Tobin RS, Burstein S. Transcatheter intracavitary fibrinolysis of infected extravascular hematomas. AJR 1987; 148: 378-380
92. Vonmoos PL, Straub PW. Absorption und hämatologische Wirkungen yon intrakavitär und oral applizierter Streptokinase - Streptodornase (Varidase). Schweiz Med Wochenschr 1979; 109: 1538-1544
93. Wait MA, Sharma S, Hohn J, Nogare AD. A randomised trial of empyema therapy. Chest 1997; 111: 1548-1551
94. Ward GLH, Heiselman DE, White LJ. Pulsus paradoxus in anaphylactic shock due to urokinase administration. Chest 1992; 101: 589
95. Widstrom O, Egberg N, Chmielewska J, Blomback M. Fibrinolytic and coagulation mechanisms in stages of inflammation: a study of BCG-induced pleural exudate in guinea pig. Thromb Res 1983; 29: 511-519
96. Willsie-Ediger SK, Salzman G, Reisz G, Foreman MG. Use of intrapleural streptokinase in the treatment of thoracic empyema. Am J Med Sci 1990; 300: 296-300